Author: OurCrowd

OurCrowd High-Tech Jobs Index Q3 2021

Demand for high-tech employees 244% higher than 2020, but post-pandemic slowdown looms Hybrid working increases Job vacancies at OurCrowd companies in Q3 2021 rise 244% year-on-year to more than 3,528; new daily vacancies rise from 31 to 47Most high-tech companies plan to slow down their hiring plans in 2022Hybrid work trend increases – more than 80% of companies expect hybrid working to continue into 2022, with employers in central Israel expanding recruitment in the peripherySoftware engineers, business development and operations specialists most in demand“We are increasing our hiring in R&D and sales. We moved to a hybrid model from complete working from home with new offices” – Kfir Kimhi, CEO, ItsMine The OurCrowd High-Tech Jobs Index is a quarterly report and data series tracking vacancies and hiring patterns at high-tech companies in Israel and abroad. All data is based on a survey and the Portfolio Jobs section of the OurCrowd website, where more than 100 portfolio companies list current vacancies (4th edition: November 2021). EXECUTIVE SUMMARY Total job vacancies rise by 244% percent from Q3 2020 to Q3 2021...

Read More

[SaNOtize in TrialSiteNews] Nasal spray stops COVID-19 in use in Israel & Bahrain—why isn’t this reported in America

At the start of 2021 TrialSite reported on UK-based NHS hospitals involved with a clinical trial involving a nasal spray that in a lab environment exhibited the ability to kill 99.9% of SARS-Cov-2, the virus behind COVID-19. Called the SaNOTize Nitric Oxide Nasal Spray (NONS), this investigational product was designed to kill COVID-19 in the upper airways, in effect inhibiting the virus from incubating and thereby making its way to the host’s lungs. Read more...

Read More